Illumina Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.Illumina Inc. (ILMN) shares rose 3.14% to $196.86, hitting a new 52-week high, despite a broader market decline where the S&P 500 and Dow Jones fell. However, Illumina underperformed relative to competitors Labcorp, Charles River Laboratories, and Quest Diagnostics, which posted larger gains. Trading volume was below its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Illumina Inc. (ILMN) rose 3.14% to $196.86 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.
Illumina Inc. hit a new 52-week high, surpassing its previous peak of $196.66, which the company achieved on July 7th.
The stock underperformed when compared to some of its competitors Thursday, as Labcorp Holdings Inc. (LH) rose 3.40% to $291.02, Charles River Laboratories International Inc. (CRL) rose 4.84% to $229.29, and Quest Diagnostics Inc. (DGX) rose 8.61% to $227.90.
Trading volume (1.2 M) remained 708,928 below its 50-day average volume of 1.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-23-26 1724ET